An AI reckoning: Why Life Sciences Has More AI Than It Can Use and What’s Still Missing: The Intelligence Layer

With any new technology, there comes an inevitable saturation point. Has life sciences reached ‘peak AI’?

AI deployment hasn’t quite reached that stage, but it’s getting there quickly. In 2025, 1,953 new AI companies were founded in the US alone, a jump of 71% from the previous year. In life sciences specifically, 79% of companies now report active AI use.

In this eBook, we explore why pharma teams should rethink where they invest in AI, how successful AI deployment should be thought of, and what’s missing in order for AI to deliver maximum value.

Fill out the form to download our latest eBook.